David Needham

6PUBLICATIONS
8CO-AUTHORS
Biologically active moleculesGlycobiologyPredictive and prognostic markersMolecular targetsMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 19, 2023
Extraction of niclosamide from commercial approved tablets into aqueous buffered solution creates potentially approvable oral and nasal sprays against COVID-19 and other respiratory infections.

David Needham

|Apr 06, 2023
LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro.

Mary S Dickinson, Miriam Kutsch, Linda Sistemich

|Feb 25, 2023
Low-Density Lipoprotein Pathway Is a Ubiquitous Metabolic Vulnerability in High Grade Glioma Amenable for Nanotherapeutic Delivery.

Adenike O Adekeye, David Needham, Ruman Rahman

|Dec 28, 2021
The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology: Motivation for Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Variants and other Viral Infections.

David Needham

|May 07, 2020
Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma.

Gireesh B Reddy, David L Kerr, Ivan Spasojevic

|Feb 06, 2019
Micro-Surface and -Interfacial Tensions Measured Using the Micropipette Technique: Applications in Ultrasound-Microbubbles, Oil-Recovery, Lung-Surfactants, Nanoprecipitation, and Microfluidics.

David Needham, Koji Kinoshita, Anders Utoft

Pageof 1

Frequent Collaborators

1 joint publications

David L Kerr

1 joint publications

Ruman Rahman

1 joint publications

Mary S Dickinson

1 joint publications

Miriam Kutsch